ICON Executive and Leadership Team

Mr Icon, the Chief Executive Officer at ICON, directs the overarching corporate strategy and operational framework. This leadership position involves guiding the company's global expansion and ensuring alignment with its mission to support pharmaceutical, biotechnology, and medical device organizations. Mr Icon oversees the integration of diverse development and commercialization services, driving innovation across all business units. The Chief Executive Officer's focus remains on enhancing ICON's market position through strategic partnerships and robust service delivery. By championing a culture of excellence, Mr Icon ensures the company consistently meets the complex needs of its clients worldwide. This executive role is central to maintaining ICON's reputation as a leader in the drug and device development sector.

Uttam Mondal, the Chief Operating Officer at ICON, manages the day-to-day operational execution and efficiency across all global functions. This role involves optimizing resource allocation and streamlining processes to support the company's drug and device development services. Uttam Mondal ensures that ICON's operational infrastructure effectively supports its clients in the pharmaceutical, biotechnology, and medical device industries. The Chief Operating Officer's responsibilities include overseeing service delivery, quality assurance, and the implementation of best practices throughout the organization. By driving operational excellence, Uttam Mondal contributes directly to ICON's ability to provide integrated development and commercialization solutions. This executive function is critical for maintaining high standards of performance and client satisfaction.

Deepali Suri, the President, ICON Biotech at ICON, directs the specialized services and strategic initiatives for the biotechnology sector. This leadership position focuses on advancing drug and device development for biotechnology firms, ensuring ICON's offerings meet the unique demands of this rapidly evolving industry. Deepali Suri oversees the integration of research, development, and commercialization strategies tailored to biotech clients. The President, ICON Biotech role involves fostering innovation and ensuring the highest standards of service delivery within this critical segment. By driving growth and operational excellence in the biotech division, Deepali Suri significantly contributes to ICON's overall mission of supporting pharmaceutical and public health advancements.

Thomas Marsland, the President at ICON, holds a key leadership position driving strategic growth and operational oversight. This executive role involves managing significant business units and ensuring the effective delivery of ICON's comprehensive drug and device development and commercialization services. Thomas Marsland focuses on enhancing client relationships and expanding market reach within the pharmaceutical and biotechnology sectors. The President's responsibilities include aligning divisional objectives with the company's overarching mission and financial targets. By leading critical operational and strategic functions, Thomas Marsland contributes to ICON's sustained success and its impact on global health initiatives.

Connie Inguanti, the President, Symphony Health at ICON, leads the strategic direction and operational execution for ICON's Symphony Health division. This specialized role focuses on leveraging data analytics and technology to support pharmaceutical, biotechnology, and public health organizations. Connie Inguanti oversees the development and delivery of advanced commercialization services, ensuring clients gain critical market insights. The President, Symphony Health position is instrumental in driving innovation within health data analytics and market access strategies. By enhancing the capabilities of the Symphony Health division, Connie Inguanti directly supports ICON's mission to accelerate the development and commercialization of life-changing therapies.

Kevin Davis, the President at ICON, directs significant operational and strategic initiatives across key business segments. This executive leadership role involves overseeing the delivery of comprehensive drug and device development and commercialization services to a diverse client base. Kevin Davis focuses on driving operational efficiency and fostering innovation within the teams managed. The President's responsibilities include ensuring seamless integration of services for pharmaceutical, biotechnology, and medical device organizations. By championing strategic objectives and operational excellence, Kevin Davis plays a vital part in advancing ICON's mission to support global health advancements and client success.

John Hubbard, the Global President at ICON, oversees the strategic direction and operational execution of ICON's services on an international scale. This critical role involves managing global teams and ensuring the consistent delivery of high-quality drug and device development and commercialization solutions. John Hubbard focuses on expanding ICON's presence and impact across diverse geographic markets, supporting pharmaceutical, biotechnology, and government health organizations. The Global President's responsibilities include driving strategic partnerships and fostering operational excellence worldwide. By leading global initiatives, John Hubbard significantly contributes to ICON's mission of accelerating the development of life-changing therapies and improving public health outcomes.

Albert Quintana, the President at ICON, directs key strategic and operational functions within the organization. This executive leadership role is focused on enhancing the delivery of ICON's comprehensive drug and device development and commercialization services. Albert Quintana oversees teams responsible for driving innovation and efficiency in supporting pharmaceutical, biotechnology, and medical device clients. The President's responsibilities include aligning divisional goals with the company's broader mission to advance healthcare solutions. By leading critical business operations, Albert Quintana contributes to ICON's sustained growth and its commitment to client success in the global market.

Marian Colon-Nieves, the Manager, Clinical Operations & Chief People Officer at ICON, spearheads both the strategic direction of clinical operations and the comprehensive management of human capital. This dual role ensures that ICON's clinical trial execution is efficient and that the organization fosters a supportive and high-performing work environment. Marian Colon-Nieves oversees the teams responsible for delivering complex clinical development services to pharmaceutical and biotechnology clients. The Chief People Officer function focuses on talent acquisition, development, and retention, crucial for maintaining ICON's expertise in drug and device commercialization. By integrating operational leadership with people strategy, Marian Colon-Nieves drives organizational effectiveness and supports the company's mission to advance healthcare solutions.